JAMA Internal Medicine

From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.

ja.ma/4sPmBkU

#ScientificSessions26

💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.

ja.ma/4sNUqTv

#ScientificSessions26

📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.

ja.ma/4sRreeq

#ScientificSessions26

Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.

ja.ma/4C81IWz

#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.

ja.ma/4fi4rm9